Close

Corcept Therapeutics (CORT) Tops Q1 EPS by 1c

May 3, 2016 4:14 PM EDT

Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.32 million.

For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings